EFG Asset Management (Americas)’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-3,693
Closed -$305K – 133
2022
Q3
$305K Sell
3,693
-4
-0.1% -$385 0.08% 115
2022
Q2
$352K Sell
3,697
-709
-16% -$73.4K 0.08% 112
2022
Q1
$519K Sell
4,406
-515
-10% -$57.8K 0.1% 110
2021
Q4
$638K Sell
4,921
-281
-5% -$32.8K 0.11% 108
2021
Q3
$589K Buy
5,202
+208
+4% +$23.7K 0.1% 109
2021
Q2
$517K Buy
4,994
+778
+18% +$73.3K 0.1% 114
2021
Q1
$353K Buy
4,216
+922
+28% +$77.9K 0.07% 121
2020
Q4
$301K Sell
3,294
-156
-5% -$12.9K 0.06% 120
2020
Q3
$275K Buy
3,450
+254
+8% +$19.8K 0.06% 123
2020
Q2
$221K Buy
+3,196
New +$227K 0.06% 120
2017
Q4
– Sell
-8,340
Closed -$304K – 134
2017
Q3
$304K Sell
8,340
-228
-3% -$8.7K 0.12% 123
2017
Q2
$338K Buy
+8,568
New +$313K 0.13% 104

Other funds holding EW

EFG Asset Management (Americas)'s EW Position: Q4 2022 in Review

EFG Asset Management (Americas) sold out of Edwards Lifesciences (EW) in Q4 2022, closing a stake of 3,693 shares — an estimated $305K sold.

EFG Asset Management (Americas) first reported a position in EW in Q2 2017 and held it in 12 quarters. The position peaked at $638K in Q4 2021. 1,229 funds tracked by Wall St. Rank hold EW as of Q4 2022.

  • EFG Asset Management (Americas) reported no remaining Edwards Lifesciences position as of Q4 2022 after selling out during the quarter.
  • EFG Asset Management (Americas) sold 3,693 Edwards Lifesciences shares in Q4 2022, an estimated $305K.
  • EFG Asset Management (Americas) first reported a position in Edwards Lifesciences in Q2 2017 and held it in 12 quarters.
  • EFG Asset Management (Americas)'s Edwards Lifesciences position peaked at $638K in Q4 2021.
  • 1,229 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2022.

Based on EFG Asset Management (Americas)'s 13F filing for Q4 2022, filed 9 Feb 2023.